Although BAK1 is not a core member of the Bcl-2 family or a commonly targeted molecule in drug development, exploring its potential as a therapeutic target for pancreatic cancer is highly significant ( 44 ).
← all excerpts
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma.
1
—
—